Meeting News Coverage

Konan releases add-on to Chart2020 VA testing application

Konan Medical has released FLEX, an add-on to the Chart2020 Duo visual acuity testing application, the company announced in a news release.

The application was presented at the American Society of Cataract and Refractive Surgery meeting in Boston.

FLEX was released on Apple iTunes for Retina display iPad devices, according to the release. The new application enables clinicians to adjust visual acuity testing distance from 33 cm, or 14 inches, to 6 meters, or 20 feet. It features industry standard Sloan specification literate, illiterate and pediatric optotypes in several languages.

The test is designed to seamlessly display acuity lines, single letters and full charts with smart randomization and reverse contrast on Retina iPad tablets.

“FLEX is on-the-fly precision acuity testing at reading distances, computer distances or even full distance vision testing,” Charles W. Stewart, OD, Konan Medical USA CEO, said in the release.

The Chart2020 application is currently used in academic, research, clinical trial and practice settings in more than 12 countries, according to the news release.

Konan Medical has released FLEX, an add-on to the Chart2020 Duo visual acuity testing application, the company announced in a news release.

The application was presented at the American Society of Cataract and Refractive Surgery meeting in Boston.

FLEX was released on Apple iTunes for Retina display iPad devices, according to the release. The new application enables clinicians to adjust visual acuity testing distance from 33 cm, or 14 inches, to 6 meters, or 20 feet. It features industry standard Sloan specification literate, illiterate and pediatric optotypes in several languages.

The test is designed to seamlessly display acuity lines, single letters and full charts with smart randomization and reverse contrast on Retina iPad tablets.

“FLEX is on-the-fly precision acuity testing at reading distances, computer distances or even full distance vision testing,” Charles W. Stewart, OD, Konan Medical USA CEO, said in the release.

The Chart2020 application is currently used in academic, research, clinical trial and practice settings in more than 12 countries, according to the news release.

    See more from American Society of Cataract and Refractive Surgery Meeting